This page shows the latest psilocybin news and features for those working in and with pharma, biotech and healthcare.
Eleusis’ trial comes after the non-profit Usona Institute launched a phase 2 trial of psilocybin – found in ‘magic mushrooms’ – as a treatment for major depressive disorder.
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Psilocybin (aka magic mushrooms) has shown promise in treating a variety of difficult-to-treat health conditions such as depression and cancer-related anxiety.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...